Écrit par Pluristem | 23 Juillet 2012

HAIFA, ISRAEL, July 18, 2012 -- Pluristem Therapeutics, Inc. (NASDAQ:PSTI; TASE: PLTR), today announced that in anticipation of initiating a Phase II study using PLX-PAD cells for the treatment of Intermittent Claudication (IC), the company has recently entered into a collaborative agreement with CPC Clinical Research (CPC) for services related to enrolling and sustaining clinical sites...

Écrit par ANRs | 23 Juillet 2012

Inaugural Global Scientific Strategy Towards an HIV Cure launched ahead of the XIX International AIDS Conference in Washington DC World´s leading HIV/AIDS Scientists and Stakeholders to gather in Washington D.C. to discuss Global Alliance on HIV Cure research


Thursday, 19 July, 2012 (Washington D.C, US)--The Inaugural Global Scientific StrategyTowards an HIV Cure was launched today ahead of...

Écrit par OMS | 23 Juillet 2012

WASHINGTON /GENÈVE | 20 juillet 2012 — L’Organisation mondiale de la Santé (OMS) a publié ses premières recommandations aux pays qui envisagent de proposer des traitements anti-VIH, connus sous le nom d’antirétroviraux (ARV) pour protéger les personnes qui ne sont pas infectées mais se trouvent exposées à un risque élevé d’infection par le virus.

Ces recommandations...

Écrit par WHO | 23 Juillet 2012

KARACHI/NEW YORK/GENEVA, 21 July 2012 – The World Health Organization (WHO) and UNICEF are deeply saddened by the killing of Mr. Muhammad Ishaq, a local community worker who was part of the polio eradication initiative in Pakistan.

Mr. Ishaq was shot and killed in the Gadap town area of Karachi on Friday evening.

Polio immunization activities were suspended in this area of Karachi earlier...